Kumar Amarjeet, Sinha Chandni, Kumar Ajeet, Kumari Poonam
Department of Anesthesia, AIIMS, Patna, Bihar, India.
Department of Anesthesia, AIIMS, New Delhi, India.
Anesth Essays Res. 2017 Jan-Mar;11(1):201-205. doi: 10.4103/0259-1162.200236.
The quest for an ideal sedative during regional anesthesia is on. Although propofol has been accepted as a sedative intraoperatively, it can be associated with troublesome hemodynamic changes. Dexmedetomidine is a new alpha 2 agonist used widely for sedation.
In this study, we tried to compare equivalent doses of dexmedetomidine infusion with propofol with emphasis on their effect on the hemodynamics.
Prospective, single-blinded randomized controlled trial.
In a single blinded study, 60 American Society of Anesthesiologists (ASA) I and II patients scheduled for forearm surgeries under brachial plexus block were randomized to receive either propofol (Group I) or dexmedetomidine (Group II) infusion. Ultrasound-guided supraclavicular brachial plexus block was given in all the patients. After confirming adequate motor and sensory blockade, they were administered an initial loading dose of the drug over 10 min followed by a maintenance dose till the end of the surgery. The rate of infusion was titrated to maintain Ramsay sedation score of 2-4. Intraoperative hemodynamic and respiratory effects were documented along with surgeon and patient satisfaction. Any adverse effect such as hypotension, bradycardia, nausea, and vomiting was also noted.
The data collected were evaluated using Stata version 10. < 0.05 was considered statistically significant.
Heart rate decreased significantly in Group II (dexmedetomidine) while mean arterial pressure decreased significantly in Group I (propofol). There was no increase in the incidence of bradycardia or hypotension in either groups. Patient satisfaction score was significantly greater in Group II (dexmedetomidine) while surgeon satisfaction score was similar in both the groups.
Dexmedetomidine at equivalent doses of propofol has a similar hemodynamic and respiratory effect, similar surgeon's satisfaction score, higher patient's satisfaction score, and no significant side effects in ASA I/II patients. Thus, dexmedetomidine may prove to be a valuable alternative to propofol for sedation in patients undergoing upper limb surgeries in brachial plexus block.
对于区域麻醉期间理想镇静剂的探索一直在进行。尽管丙泊酚在术中已被公认为一种镇静剂,但它可能会伴有棘手的血流动力学变化。右美托咪定是一种广泛用于镇静的新型α2激动剂。
在本研究中,我们试图比较等效剂量的右美托咪定输注与丙泊酚,重点关注它们对血流动力学的影响。
前瞻性、单盲随机对照试验。
在一项单盲研究中,将60例计划在臂丛阻滞下进行前臂手术的美国麻醉医师协会(ASA)I级和II级患者随机分为接受丙泊酚输注组(I组)或右美托咪定输注组(II组)。所有患者均接受超声引导下锁骨上臂丛阻滞。确认运动和感觉阻滞充分后,在10分钟内给予患者初始负荷剂量的药物,随后给予维持剂量直至手术结束。输注速率进行滴定以维持 Ramsay 镇静评分在2 - 4分。记录术中血流动力学和呼吸效应以及外科医生和患者的满意度。还记录了任何不良反应,如低血压、心动过缓、恶心和呕吐。
使用Stata 10版本对收集的数据进行评估。P < 0.05被认为具有统计学意义。
II组(右美托咪定)心率显著降低,而I组(丙泊酚)平均动脉压显著降低。两组心动过缓或低血压的发生率均未增加。II组(右美托咪定)患者满意度评分显著更高,而两组外科医生满意度评分相似。
在ASA I/II级患者中,等效剂量的右美托咪定与丙泊酚具有相似的血流动力学和呼吸效应、相似的外科医生满意度评分、更高的患者满意度评分且无显著副作用。因此,右美托咪定可能被证明是臂丛阻滞下上肢手术患者镇静时丙泊酚的一种有价值的替代药物。